Transaction · 0001140361-26-035375

Venker Eric

Venker Eric, PRES, IC, reported a transaction classified as exercise at Roivant Sciences Ltd. involving 200000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 3844834.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES, IC
ROIVRoivant Sciences Ltd.
Trade date
Aug 28, 2026
Filing date
Sep 02, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded200k$0.00 per share
Holdings after3.84MDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ROIV price since this filing

Daily closing prices, with the filing date and available return windows
ROIV · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -3.9%1w ago +6.2%1d ago +9.9%
Returns since7d +22.3%30d +3.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001140361-26-035375
Stock Option (Right to Buy)
Transaction date
Aug 28, 2026
Filed Sep 02, 2026, 01:00 AM · 5d delay
Shares
200,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
3,844,834 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & Immunovant CEO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.17 to $36.16, inclusive. The reporting person undertakes to provi…

  2. F2

    The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.17 to $36.80, inclusive. The reporting person undertakes to provi…

  3. F3

    Reflects an award of stock options to purchase Common Shares that is fully vested.

Original filing · 0001140361-26-035375
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ROIV